1. Pathogenesis of pulmonary fibrosis: implications for pharmacological intervention;Coker, R.K.; Laurent, G.J.,1995
2. Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro;Cambrey, A.; Harrison, N.K.; Dawes, K.E.; Southcott, A.M.; Black, C.M.; du Bois, R.M.;Am J Respir Cell Mol Biol,1994
3. Role of thrombin in pulmonary fibrosis;Hernandez-Rodriguez, N.A.; Cambrey, A.D.; Harrison, N.K.; Chambers, R.C.; Gray, A.J.; Southcott, A.M.;Lancet,1995
4. Transforming growth factor 1,-2 and - 3 all stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycininduced lung fibrosis;Coker, R.K.; Laurent, G.J.; Shahzeidi, S.; Lympany, P.A.; du Bois, R.M.; Jeffery, P.K.;Am J Pathol,1997
5. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice;Piguet, P.F.; Vesin, C.;Eur Respir J,1994